244 related articles for article (PubMed ID: 33914124)
1. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
[TBL] [Abstract][Full Text] [Related]
2. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.
Clairet AL; Boiteux-Jurain M; Curtit E; Jeannin M; Gérard B; Nerich V; Limat S
Med Oncol; 2019 Apr; 36(5):45. PubMed ID: 30993543
[TBL] [Abstract][Full Text] [Related]
3. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
[TBL] [Abstract][Full Text] [Related]
4. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance.
Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C
J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392
[TBL] [Abstract][Full Text] [Related]
5. Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians.
Chan A; Yap KY; Koh D; Low XH; Cheung YT;
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):939-47. PubMed ID: 21732473
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management.
Bellesoeur A; Gataa I; Jouinot A; Mershati SE; Piketty AC; Tlemsani C; Balakirouchenane D; Monribot A; Vidal M; Batista R; de Percin S; Villeminey C; Alexandre J; Goldwasser F; Blanchet B; Boudou-Rouquette P; Thomas-Schoemann A
Cancer Chemother Pharmacol; 2021 Oct; 88(4):741-751. PubMed ID: 34304283
[TBL] [Abstract][Full Text] [Related]
7. Real-world data on herb-drug interactions in oncology: A scoping review of pharmacoepidemiological studies.
Lam CS; Koon HK; Ma CT; Au KY; Zuo Z; Chung VC; Cheung YT
Phytomedicine; 2022 Aug; 103():154247. PubMed ID: 35716539
[TBL] [Abstract][Full Text] [Related]
8. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
Kim SH; Suh Y; Ah YM; Jun K; Lee JY
Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
10. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
11. Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation.
Rodrigues J; Marques P; Gomes C; Portela C
Cureus; 2023 Feb; 15(2):e35324. PubMed ID: 36994248
[TBL] [Abstract][Full Text] [Related]
12. Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology.
Drozdoff L; Klein E; Kalder M; Brambs C; Kiechle M; Paepke D
Integr Cancer Ther; 2019; 18():1534735419846392. PubMed ID: 31046491
[TBL] [Abstract][Full Text] [Related]
13. Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.
Obreli Neto PR; Nobili A; de Lyra DP; Pilger D; Guidoni CM; de Oliveira Baldoni A; Cruciol-Souza JM; de Carvalho Freitas AL; Tettamanti M; Gaeti WP; Nakamura Cuman RK
J Pharm Pharm Sci; 2012; 15(2):332-43. PubMed ID: 22579011
[TBL] [Abstract][Full Text] [Related]
14. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
16. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
Chan A; Tan SH; Wong CM; Yap KY; Ko Y
Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics.
Bossaer JB; Eskens D; Gardner A
J Oncol Pharm Pract; 2022 Jan; 28(1):82-86. PubMed ID: 33435823
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug interactions of cytostatics with regular medicines in lung cancer patients.
Rompelman FM; Smit AA; Franssen EJ; Crul M
J Oncol Pharm Pract; 2017 Oct; 23(7):483-490. PubMed ID: 27530243
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
20. Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy.
Leenhardt F; Alexandre M; Guiu S; Pouderoux S; Beaujouin M; Lossaint G; Philibert L; Evrard A; Jacot W
Cancer Chemother Pharmacol; 2021 Oct; 88(4):723-729. PubMed ID: 34286354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
